BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26657056)

  • 1. High throughput screening technologies for ion channels.
    Yu HB; Li M; Wang WP; Wang XL
    Acta Pharmacol Sin; 2016 Jan; 37(1):34-43. PubMed ID: 26657056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-Based Functional Assays for Ca
    Cordero-Sánchez C; Mudarra-Fraguas I; Fernández-Carvajal A
    Methods Mol Biol; 2019; 1987():99-110. PubMed ID: 31028676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput assay technologies for ion channel drug discovery.
    Zheng W; Spencer RH; Kiss L
    Assay Drug Dev Technol; 2004 Oct; 2(5):543-52. PubMed ID: 15671652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTS assays for developing the molecular pharmacology of ion channels.
    McManus OB
    Curr Opin Pharmacol; 2014 Apr; 15():91-6. PubMed ID: 24556186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel screening techniques for ion channel targeting drugs.
    Obergrussberger A; Stölzle-Feix S; Becker N; Brüggemann A; Fertig N; Möller C
    Channels (Austin); 2015; 9(6):367-75. PubMed ID: 26556400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay technologies for screening ion channel targets.
    Mattheakis LC; Savchenko A
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioluminescence Methodology for Ion Channel Studies.
    Wadsworth PA; Singh AK; Nguyen N; Stephan C; Laezza F
    Methods Mol Biol; 2021; 2188():191-228. PubMed ID: 33119853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling.
    Du Y; Days E; Romaine I; Abney KK; Kaufmann K; Sulikowski G; Stauffer S; Lindsley CW; Weaver CD
    ACS Chem Neurosci; 2015 Jun; 6(6):871-8. PubMed ID: 25879403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion channel pharmacology under flow: automation via well-plate microfluidics.
    Spencer CI; Li N; Chen Q; Johnson J; Nevill T; Kammonen J; Ionescu-Zanetti C
    Assay Drug Dev Technol; 2012 Aug; 10(4):313-24. PubMed ID: 22574656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of high-throughput screening.
    Entzeroth M; Flotow H; Condron P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of FLIPR high throughput calcium assays for ion channels and GPCRs.
    Vetter I
    Adv Exp Med Biol; 2012; 740():45-82. PubMed ID: 22453938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Automated Technologies to Ion Channel Drug Discovery.
    Picones A; Loza-Huerta A; Segura-Chama P; Lara-Figueroa CO
    Adv Protein Chem Struct Biol; 2016; 104():357-378. PubMed ID: 27038379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in ion channel screening for drug discovery: are there ways to improve its productivity?
    Farre C; Fertig N
    Expert Opin Drug Discov; 2014 Oct; 9(10):1103-7. PubMed ID: 25062795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the advancing high-throughput screening techniques for patch clamp-based ion channel screens: implications for drug discovery.
    Obergrussberger A; Goetze TA; Brinkwirth N; Becker N; Friis S; Rapedius M; Haarmann C; Rinke-Weiß I; Stölzle-Feix S; Brüggemann A; George M; Fertig N
    Expert Opin Drug Discov; 2018 Mar; 13(3):269-277. PubMed ID: 29343120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
    Trivedi S; Dekermendjian K; Julien R; Huang J; Lund PE; Krupp J; Kronqvist R; Larsson O; Bostwick R
    Assay Drug Dev Technol; 2008 Apr; 6(2):167-79. PubMed ID: 18078380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro- and nano-technologies for lipid bilayer-based ion-channel functional assays.
    Hirano-Iwata A; Ishinari Y; Yamamoto H; Niwano M
    Chem Asian J; 2015 Jun; 10(6):1266-74. PubMed ID: 25702941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flux assays in high throughput screening of ion channels in drug discovery.
    Gill S; Gill R; Lee SS; Hesketh JC; Fedida D; Rezazadeh S; Stankovich L; Liang D
    Assay Drug Dev Technol; 2003 Oct; 1(5):709-17. PubMed ID: 15090243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion channel drug discovery: challenges and future directions.
    Wickenden A; Priest B; Erdemli G
    Future Med Chem; 2012 Apr; 4(5):661-79. PubMed ID: 22458684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channel screening.
    Dunlop J; Bowlby M; Peri R; Tawa G; LaRocque J; Soloveva V; Morin J
    Comb Chem High Throughput Screen; 2008 Aug; 11(7):514-22. PubMed ID: 18694388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for ion channel modulators.
    Falconer M; Smith F; Surah-Narwal S; Congrave G; Liu Z; Hayter P; Ciaramella G; Keighley W; Haddock P; Waldron G; Sewing A
    J Biomol Screen; 2002 Oct; 7(5):460-5. PubMed ID: 14599362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.